Xencor, Inc Current Liabilities
Xencor, Inc (XNCR) had Current Liabilities of $81.86 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Liabilities, Current $81.86M.
- 2026-03-31: Liabilities, Current $73.46M.
- 2025-12-31: Liabilities, Current $95.91M.
- 2025-09-30: Liabilities, Current $86.48M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $81.86M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $73.46M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $95.91M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $86.48M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $96.08M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $88.44M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $87.43M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $90.81M 10-Q/A · filed 2025-02-24 | $91.97M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $75.59M 10-Q/A · filed 2025-02-24 | $80.08M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $71.08M 10-Q/A · filed 2025-02-24 | $79.40M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $73.92M 10-K · filed 2025-02-27 | $84.71M 10-K · filed 2024-02-29 |
| 2023-09-30 | $53.04M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $44.63M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $65.06M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $63.84M 10-K/A · filed 2025-02-24 | |
| 2022-09-30 | $90.03M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $75.04M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $60.94M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $70.74M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $44.32M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $45.96M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $99.93M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $121.06M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $70.49M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $66.45M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $65.92M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $66.56M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $64.31M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $63.71M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $73.32M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $53.85M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $52.03M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $71.16M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $73.43M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $72.65M 10-K · filed 2019-02-26 | $101.34M 10-K · filed 2018-02-28 |
| 2017-09-30 | $100.33M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $107.43M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $106.88M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $106.29M 10-K · filed 2018-02-28 | |
| 2016-09-30 | $110.67M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $115.95M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $34.26M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $43.43M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $56.58M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $8.41M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $6.88M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $6.20M 10-K · filed 2016-03-08 | |
| 2014-09-30 | $9.93M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $5.95M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $6.83M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $7.48M 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |